T0	Participants 230 290	patients with refractory monosymptomatic nocturnal enuresis.
T1	Participants 334 415	28 patients with refractory monosymptomatic nocturnal enuresis to 2 equal groups.
T2	Participants 837 927	13 patients (46.4%) had detrusor overactivity and 14 (50%) had decreased bladder capacity.
T3	Participants 1629 1689	patients with refractory monosymptomatic nocturnal enuresis.